Table 1 Participant stratification by age, BMI, BI-RADS density, and duration of hormone therapy.

From: Dual-energy three-compartment breast imaging for compositional biomarkers to improve detection of malignant lesions

 

N

Percentage

Participants

349

100

Age

  

<40

20

6

40 to <50

120

34

50 to <60

118

34

60 to <70

57

16

70 to <80

30

9

≥80

4

1

BMI

  

<18.5

9

3

18.5 to <25

120

34

25 to <30

92

26

≥30

128

37

BI-RADS

  

A

23

7

Density

  

B

130

37

C

162

46

D

34

10

Hormone therapy

  

None

321

92

<5 years

10

3

≥5 years

18

5

Back to article page